Mingyuan LI

Assistant Prof. Mingyuan Li

Contact: lmynano@tust.edu.cn

Her research focuses on targeting drug delivery system, tumor therapy, new formulations and preparations. She has many publications, including Oncotarget., Pharm. Res., J. Control Release, Nanomedicine: NBM, etc.

Publications:

1 Mingyuan Li, Zhiping Li, Yang Yang, Zhiyuan Wang, Zhenbo Yang, Bingsheng Li, Xiangyang Xie, Jinwen Song, Hui Zhang, Ying Li, Guangyu Gao, Jingyuan Yang, Xingguo Mei, Wei Gong.Thermo-sensitive liposome co-loaded of vincristine and doxorubicin based on their similar physicochemical properties had synergism on tumor treatment. Pharmaceutical Research. 2016, 33: 1881-1898; (IF=3.26)

2 Mingyuan Li, Zhiyuan Wang, Hui Zhang, Yang Yang, Xiangyang Xie, Ying Li, WeiGong, Bingsheng Li, Jinwen Song, Zhenbo Yang, Xingguo Mei. Sulfate vincristine thermosensitive liposomes (VTSL) with excellent physico-chemical characteristics result in effective tumor growth delay in nude mice. Nanomedicine: Nanotechnology, Biology, and Medicine. 2016, 12: 558-559; (IF=5.67)

3 Mingyuan Li, Zhiping Li, Zhenbo Yang, Xingguo Mei. The Origin of Nanotoxicity: Physical Damage. Journal of pharmaceutical research and clinical practice. 2016, 6(1): 44-45; (IF=3.80)

4 Mingyuan Li, Hui Zhang, Guangyu Gao, Xiangyang Xie, Nan Liu, Yang Yang, Xingguo Mei.Thermo-sensitive liposomes tri-loaded with doxorubicin, vincristine, and salinomycin for co-inhibition of cancer cells and cancer stem cells. Journal of Controlled Release. 2017, 259: 96-97; (IF=7.44)

5 Siyu Ma*, Mingyuan Li*, Nan Liu, Ying Li, Zhiping Li, Yang yang, Fanglin Yu, Xiaoqin Hu, Cheng Liu, Xingguo Mei.Vincristine liposomes with smaller particle size have stronger diffusion ability in tumor and improve tumor accumulation of vincristine significantly. Oncotarget. 2017, 8(50): 87276-87291; (IF=5.17)